Clinical trial
Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension
NCT07314814 is registered in ClinicalTrials.gov with Prof. Valérie Mc Lin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension
- Lead sponsor
- Prof. Valérie Mc Lin
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- January 31, 2030
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital portosystemic shunt, portopulmonary hypertension, pulmonary arterial hypertension (pah)